Under the terms of this agreement — signed on June 19 at the 2012 BIO International Convention in Boston, Mass., USA — the two entities will study how the technology developed by HHI can be used in the detection, diagnosis and treatment of medical conditions. Johns Hopkins University School of Medicine researchers with clinical expertise in a variety of specialty areas, including oncology and infectious diseases, will collaborate with HHI’s scientists and engineers.
“Johns Hopkins is thrilled to partner with a proven global leader whose knowledge and experience matches our longstanding tradition of excellence in patient care and research,” says Helen Montag, corporate relations director of The Johns Hopkins University. “This partnership will allow us to introduce an emerging technology into the medical field to advance care for patients around the globe.”
"This collaboration will leverage both of our organizations’ best-in-class abilities to jointly develop new point-of-care clinical tools," says Frank Menzler, Fraunhofer Heinrich Hertz Institute's senior director, USA. "We are very excited to fuse Fraunhofer HHI's sensor technologies with Johns Hopkins’ clinical experience."
Fraunhofer Heinrich Hertz Institute is one of 80 institutions affiliated with Fraunhofer-Gesellschaft, Europe’s largest applied research organization, with an annual operating research budget of 2.5 billion. The Fraunhofer Heinrich Hertz Institute offers a broad range of research expertise, from optical communication networks, systems and components, to mobile broadband systems, electronic-imaging technologies and optical-sensor technologies.
The National Science Foundation has ranked JHU number one among U.S. academic institutions in total science, medical and engineering research and development spending for 32 consecutive years. To date, 36 Nobel Prize winners have been affiliated with JHU, and the university's research is among the most cited in the world.